Detalles de la búsqueda
1.
Plasma potassium concentration and cardiac repolarisation markers, Tpeak-Tend and Tpeak-Tend/QT, during and after exercise in healthy participants and in end-stage renal disease.
Eur J Appl Physiol
; 122(3): 691-702, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35048183
2.
Potassium homoeostasis and pathophysiology of hyperkalaemia.
Eur Heart J Suppl
; 21(Suppl A): A2-A5, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30837798
3.
CardioScape mapping the cardiovascular funding landscape in Europe.
Eur Heart J
; 39(25): 2423-2430, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28449050
4.
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
Eur Heart J
; 40(36): 3010-3012, 2019 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31541549
5.
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J
; 39(24): 2274-2281, 2018 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29126266
6.
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).
Europace
; 20(5): 731-732an, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438514
7.
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
Eur Heart J
; 38(3): 143-153, 2017 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28158518
8.
Comprehensive efforts to increase adherence to statin therapy.
Eur Heart J
; 38(32): 2473-2479, 2017 08 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077470
9.
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.
Eur Heart J
; 38(22): 1710-1716, 2017 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26705385
10.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Eur Heart J
; 37(13): 1015-23, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26984863
11.
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).
Eur Heart J
; 37(3): 267-315, 2016 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320110
12.
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(4): 406-419, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092425
13.
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(1): 85-99, 2022 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33638977
14.
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 8(1): 100-103, 2022 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463331
15.
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
Eur Heart J
; 36(40): 2677-80, 2015 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25948737
16.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Eur Heart J
; 36(41): 2793-2867, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320108
17.
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials.
Eur Heart J Cardiovasc Pharmacother
; 7(5): 453-459, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33135079
18.
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J Cardiovasc Pharmacother
; 7(6): 557-567, 2021 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956964
19.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Europace
; 17(11): 1601-87, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26318695
20.
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Eur Heart J
; 35(35): 2383-431, 2014 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25086026